Diels; Gaston Stanislas Marcella

Patent Applications and Registrations

Patent applications and USPTO patent grants for Diels; Gaston Stanislas Marcella.The latest application filed is for "novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors".

Company Profile

7.18.22

Diels; Gaston Stanislas Marcella - Turnhout BE
Diels; Gaston Stanislas Marcella - Beerse BE
DIELS; Gaston Stanislas Marcella - Ravels BE
Diels; Gaston Stanislas Marcella - B-2340 Beerse BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors Grant 11,318,157 - Wu , et al. May 3, 2	2022-05-03
Novel Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 Inhibitors App 20210371433 - Wu; Tongfei ; et al.	2021-12-02
Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors Grant 11,098,062 - Wu , et al. August 24, 2	2021-08-24
Pyrazole derivatives as MALT1 inhibitors Grant 11,040,031 - Lu , et al. June 22, 2	2021-06-22
Substituted nucleoside analogues for use as PRMT5 inhibitors Grant 10,898,504 - Berthelot , et al. January 26, 2	2021-01-26
Pyrazole derivatives as MALT1 inhibitors Grant 10,888,550 - Lu , et al. January 12, 2	2021-01-12
Novel 6-6 Bicyclic Aromatic Ring Substituted Nucleoside Analogues For Use As Prmt5 Inhibitors App 20200360416 - Wu; Tongfei ; et al.	2020-11-19
Novel Substituted Nucleoside Analogues For Use As Prmt5 Inhibitors App 20200289539 - BERTHELOT; Didier Jean-Claude ; et al.	2020-09-17
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors Grant 10,653,711 - Wu , et al.	2020-05-19
Pyrazole Derivatives As Malt1 Inhibitors App 20190381019 - Lu; Tianbao ; et al.	2019-12-19
Pyrazole Derivatives As Malt1 Inhibitors App 20190381012 - LU; Tianbao ; et al.	2019-12-19
Novel Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As Prmt5 Inhibitors App 20190263833 - WU; Tongfei ; et al.	2019-08-29
Novel 6-6 Bicyclic Aromatic Ring Substituted Nucleoside Analogues For Use As Prmt5 Inhibitors App 20180243328 - Wu; Tongfei ; et al.	2018-08-30
Macrocylic Pyrimidine Derivatives App 20170022202 - DIELS; Gaston Stanislas Marcella ; et al.	2017-01-26
Macrocylic Pyridine Derivatives App 20170022201 - Diels; Gaston Stanislas Marcella ; et al.	2017-01-26
Quinazoline Derivatives App 20160207938 - FREYNE; Eddy Jean Edgard ; et al.	2016-07-21
Quinazoline derivatives Grant 9,273,013 - Freyne , et al. March 1, 2	2016-03-01
Quinazoline Derivatives App 20130178624 - FREYNE; Eddy Jean Edgard ; et al.	2013-07-11
Quinazoline derivatives Grant 8,394,786 - Freyne , et al. March 12, 2	2013-03-12
Indolin-2-ones and aza-indolin-2-ones Grant 8,338,422 - Diels , et al. December 25, 2	2012-12-25
Pyrrolopyrimidines Grant 8,318,731 - Diels , et al. November 27, 2	2012-11-27
Pyrrolopyrimidines App 20100204197 - Diels; Gaston Stanislas Marcella ; et al.	2010-08-12
Indolin-2-ones And Aza-indolin-2-ones App 20100190786 - Diels; Gaston Stanislas Marcella ; et al.	2010-07-29
Quinazoline derivatives App 20100105668 - Freyne; Eddy Jean Edgard ; et al.	2010-04-29
Macrocyclic quinazoline derivatives as antiproliferative agents Grant 7,648,975 - Freyne , et al. January 19, 2	2010-01-19
Heteroaryl amines as glycogen synthase kinase 3.beta. inhibitors (GSK3 inhibitors) Grant 7,514,445 - Freyne , et al. April 7, 2	2009-04-07
Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists Grant 7,410,970 - Janssens , et al. August 12, 2	2008-08-12
Dimeric Piperidine Derivatives App 20080015225 - Cik; Miroslav ; et al.	2008-01-17
Dimeric Compounds Of Piperidine, Piperazine Or Morpholine Or Their 7-Membered Analogs Suitable For The Treatment Of Neurodegenerative Disorders App 20070299109 - Cik; Miroslav ; et al.	2007-12-27
2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity Grant 7,138,403 - Love , et al. November 21, 2	2006-11-21
Macrocyclic quinazoline derivatives as antiproliferative agents App 20060247237 - Freyne; Eddy Jean Edgard ; et al.	2006-11-02
Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists App 20060167008 - Janssens; Frans Eduard ; et al.	2006-07-27
6-Azauracil derivatives as IL-5 inhibitors Grant 6,951,857 - Freyne , et al. October 4, 2	2005-10-04
Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) App 20050004125 - Freyne, Eddy Jean Edgard ; et al.	2005-01-06
2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity App 20040254192 - Love, Christopher John ; et al.	2004-12-16
6-azauracil derivatives as IL-5 inhibitors Grant 6,743,792 - Freyne , et al. June 1, 2	2004-06-01
6-Azauracil derivatives as IL-5 inhibitors App 20030220331 - Freyne, Eddy Jean Edgard ; et al.	2003-11-27
1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatves Grant 6,403,805 - Freyne , et al. June 11, 2	2002-06-11
6-azauracil derivatives as IL-5 inhibitors App 20020042416 - Freyne, Eddy Jean Edgard ; et al.	2002-04-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.